PTK2 and cancer: Recent studies have linked specific mutation dependency of cancer cells on integrin-FAK signaling, such as NF2 tumor suppressor loss in mesothelioma and Ph+ B-cell acute lymphocytic leukemias that are especially sensitive to FAK inhibition [20, 21].